Effect of a nicotinic-acid analogue on raised plasma-free-fatty-acids after acute myocardial infarction.
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000517:prevention & control; D001786:Blood Glucose / Q000032:analysis; D055598:Chemical Phenomena; D002621:Chemistry; D002986:Clinical Trials as Topic; D005230:Fatty Acids, Nonesterified / Q000097:blood*; D005260:Female; D005461:Fluorine / Q000009:adverse effects / Q000627:therapeutic use; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D000432:Methanol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy*; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology; D010865:Pilot Projects; D010919:Placebos; D011725:Pyridines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D010919:Placebos; D011725:Pyridines; D005461:Fluorine; D009638:Norepinephrine; D000432:Methanol